2,396
Views
248
CrossRef citations to date
0
Altmetric
Review Article

Silver as an antimicrobial: facts and gaps in knowledge

&
Pages 373-383 | Received 20 Mar 2012, Accepted 16 Jul 2012, Published online: 28 Aug 2012

References

  • Adams NWH, Kramer JR. (1998). Reactivity of Ag1 ion with thiol ligands in the presence of iron sulfide. Environ Toxicol Chem, 17, 625–629.
  • Agency for Toxic Substances and Disease Registry. (2012). Toxic substances: silver 1990. Available at: http://www.atsdr.cdc.gov/. Accessed 16 March 2012.
  • Banerjee M, Mallick S, Paul A, Chattopadhyay A, Ghosh SS. (2010). Heightened reactive oxygen species generation in the antimicrobial activity of a three component iodinated chitosan-silver nanoparticle composite. Langmuir, 26, 5901–5908.
  • Bard CC, Murphy JJ, Stone DL, Terhaar CJ. (1976). Silver in photo processing effluents. J Water Pollut Control Fed, 48, 389–394.
  • Benoit G, Oktay-Marshall SD, Cantu SD II, Hood EM, Coleman CH, Corapcioglu MO, Santschi PH. (1994). Partitioning of Cu,Pb, Ag, Zn, Fe, Al, and Mn between filter-retained particles, colloids, and solution in six Texas estuaries. Mar Chem, 45, 307–336.
  • Berra L, Curto F, Li Bassi G, Laquerriere P, Pitts B, Baccarelli A, Kolobow T. (2008). Antimicrobial-coated endotracheal tubes: an experimental study. Intensive Care Med, 34, 1020–1029.
  • Biddinger GR, Gloss SP. (1984). The importance of trophic transfer in the bioaccumulation of chemical contaminants in aquatic ecosystems. Residue Rev, 91, 103–145.
  • Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann MC. (2005). In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci, 88, 412–419.
  • Bridges K, Lowbury EJ. (1977). Drug resistance in relation to use of silver sulphadiazine cream in a burns unit. J Clin Pathol, 30, 160–164.
  • Bridges K, Kidson A, Lowbury EJ, Wilkins MD. (1979). Gentamicin- and silver-resistant pseudomonas in a burns unit. Br Med J, 1, 446–449.
  • British National Formulary. (2011) Issue 58. Oxford: Pharmaceutical Press.
  • Cason JS, Jackson DM, Lowbury EJ, Ricketts CR. (1966). Antiseptic and aseptic prophylaxis for burns: use of silver nitrate and of isolators. Br Med J, 2, 1288–1294.
  • Cason JS, Lowbury EJ. (1968). Mortality and infection in extensively burned patients treated with silver-nitrate compresses. Lancet, 1, 651–654.
  • Choi O, Deng KK, Kim NJ, Ross L Jr, Surampalli RY, Hu Z. (2008). The inhibitory effects of silver nanoparticles, silver ions, and silver chloride colloids on microbial growth. Water Res, 42, 3066–3074.
  • Corbett RJ. (1996). An inorganic biocide using a novel presentation of silver. Int J Cosmet Sci, 18, 151–165.
  • Costerton JW, Ingram JM, Cheng KJ. (1974). Structure and function of the cell envelope of gram-negative bacteria. Bacteriol Rev, 38, 87–110.
  • Cowan CE, Jenne EA, Crecelius EA. (1985). Silver speciation in seawater : The importance of sulfide and organic complexation. In: Sigleo AC, Hattori A, editors. Marine and estuarine geochemistry. Chelsea, MI: Lewis. 135–303.
  • Crocetti G, Miller G. (2012). Nano-silver – policy failure puts public health at risk. Available at: http://nano.foe.org.au/node/26. Accessed on: 31 January 2012.
  • Cutter GA, Radford-Knoery J. (1994). Examining trace metal complexation by hydrogen sulfide species at nanomolar concentrations: New approaches and implications for silver. Proceedings, 2nd Argentum International Conference on the Transport, Fate, and Effects of Silver in the Environment. Madison, WI, USA. 11–14, 5–9.
  • Davis IJ, Richards H, Mullany P. (2005). Isolation of silver- and antibiotic-resistant Enterobacter cloacae from teeth. Oral Microbiol Immunol, 20, 191–194.
  • Deshpande LM, Chopade BA. (1994). Plasmid mediated silver resistance in Acinetobacter baumannii. Biometals, 7, 49–56.
  • Doudoroff P, Katz M. (1953).Critical review of literature on the toxicity of industrial wastes and their components to fish, II. The metals, as salts. Sewage Ind Wastes, 25, 802–812.
  • Dunne SM, Gainsford ID, Wilson NH. (1997). Current materials and techniques for direct restorations in posterior teeth. Part 1: Silver amalgam. Int Dent J, 47, 123–136.
  • Edwards-Jones V. (2009). The benefits of silver in hygiene, personal care and healthcare. Lett Appl Microbiol, 49, 147–152.
  • Emamifar A, Kadivar M, Shahedi M, Soleimanian-Zad S. (2011) Effect of nanocomposite packaging containing Ag and ZnO on inactivation of Lactobacillus plantarum in orange juice. Food Control, 22, 408–413.
  • European Commission. (1998). Directive 98/8/EC Concerning the placing of biocidal products on the market. http://europa.eu/legislation_summaries/food_safety/contamination_environmental_factors/l21178_en.htm (accessed 9 August 2012)
  • Fox CL Jr. (1968). Silver sulfadiazine–a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns. Arch Surg, 96, 184–188.
  • Fraser JF, Cuttle L, Kempf M, Kimble RM. (2004). Cytotoxicity of topical antimicrobial agents used in burn wounds in Australasia. ANZ J Surg, 74, 139–142.
  • Fernández A, Picouet P, Lloret E. (2010a). Cellulose-silver nanoparticle hybrid materials to control spoilage-related microflora in absorbent pads located in trays of fresh-cut melon. Int J Food Microbiol, 142, 222–228.
  • Fernández A, Soriano E, Hernández-Muñoz P, Gavara R. (2010b). Migration of antimicrobial silver from composites of polylactide with silver zeolites. J Food Sci, 75, E186–E193.
  • Forsythe BL II, La Point TW, Cobb GP, Klaine SJ. (1996). Silver in an experimental freshwater ecosystem. Proceedings, 4th Argentum International Conference on the Transport, Fate, and Effects of Silver in the Environment, Madison, WI, USA. 25–28, 185–189.
  • Galvez F, Hogstrand C, McGeer J, Bureau D, Wood CM. (1996). The physiological effects of dietary silver exposure in juvenile rainbow trout (Oncorhynchus mykiss). Proceedings, 4th Argentum International Conference on the Transport, Fate, and Effects of Silver in the Environment, Madison, WI, USA. 25–28, 165–174.
  • Garner JP, Heppell PS. (2005a). The use of Flammacerium in British Burns Units. Burns, 31, 379–382.
  • Garner JP, Heppell PS. (2005b). Cerium nitrate in the management of burns. Burns, 31, 539–547.
  • Gayle WE, Mayhall CG, Lamb VA, Apollo E, Haynes BW Jr. (1978). Resistant Enterobacter cloacae in a burn center: the ineffectiveness of silver sulfadiazine. J Trauma, 18, 317–323.
  • Gogoi SK, Gopinath P, Paul A, Ramesh A, Ghosh SS, Chattopadhyay A. (2006). Green fluorescent protein-expressing Escherichia coli as a model system for investigating the antimicrobial activities of silver nanoparticles. Langmuir, 22, 9322–9328.
  • Gottschalk F, Sonderer T, Scholz RW, Nowack B. (2010). Possibilities and limitations of modeling environmental exposure to engineered nanomaterials by probabilistic material flow analysis. Environ Toxicol Chem, 29, 1036–1048.
  • Guiné V, Spadini L, Sarret G, Muris M, Delolme C, Gaudet JP, Martins JM. (2006). Zinc sorption to three gram-negative bacteria: combined titration, modeling, and EXAFS study. Environ Sci Technol, 40, 1806–1813.
  • Gupta A, Silver S. (1998). Silver as a biocide: will resistance become a problem? Nat Biotechnol, 16, 888.
  • Gupta A, Matsui K, Lo JF, Silver S. (1999). Molecular basis for resistance to silver cations in Salmonella. Nat Med, 5, 183–188.
  • Gupta A, Phung LT, Taylor DE, Silver S. (2001). Diversity of silver resistance genes in IncH incompatibility group plasmids. Microbiology (Reading, Engl), 147, 3393–3402.
  • Haefeli C, Franklin C, Hardy K. (1984). Plasmid-determined silver resistance in Pseudomonas stutzeri isolated from a silver mine. J Bacteriol, 158, 389–392.
  • Hartemann P, Goeffert M, Blech MF. (1995). Efficacité bactericide du peroxide d’hydrogène sur Escherichia coli. Ann Med Nancy, 34, 85–88.
  • Heggers J, Goodheart RE, Washington J, McCoy L, Carino E, Dang T, Edgar P, Maness C, Chinkes D. (2005). Therapeutic efficacy of three silver dressings in an infected animal model. J Burn Care Rehabil, 26, 53–56.
  • Hendry AT, Stewart IO. (1979). Silver-resistant Enterobacteriaceae from hospital patients. Can J Microbiol, 25, 915–921.
  • Hoogstrand C, Wood C. (1998). Toward a better understanding of the bioavailability, physiology and toxicity of silver in fish: implications for water quality criteria. Environ ToxChem, 17, 547–561.
  • Huang L, Dai T, Xuan Y, Tegos GP, Hamblin MR. (2011). Synergistic combination of chitosan acetate with nanoparticle silver as a topical antimicrobial: efficacy against bacterial burn infections. Antimicrob Agents Chemother, 55, 3432–3438.
  • Hsu SH, Tseng HJ, Lin YC. (2010). The biocompatibility and antibacterial properties of waterborne polyurethane-silver nanocomposites. Biomaterials, 31, 6796–6808.
  • Hwang ET, Lee JH, Chae YJ, Kim YS, Kim BC, Sang BI, Gu MB. (2008). Analysis of the toxic mode of action of silver nanoparticles using stress-specific bioluminescent bacteria. Small, 4, 746–750.
  • ISO 22196. (2011) Measurement of antibacterial activity on plastics and other non-porous surfaces. Geneva: International Organization for Standardization.
  • Jin X, Li M, Wang J, Marambio-Jones C, Peng F, Huang X, Damoiseaux R, Hoek EM. (2010). High-throughput screening of silver nanoparticle stability and bacterial inactivation in aquatic media: influence of specific ions. Environ Sci Technol, 44, 7321–7328.
  • JIS Z 2801. (2000). Antimicrobial products – test for antimicrobial activity and efficacy. Tokyo: Japanese Standards Association.
  • Johnston HJ, Hutchison G, Christensen FM, Peters S, Hankin S, Stone V. (2010). A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol, 40, 328–346.
  • Kaur P, Vadehra DV. (1986). Mechanism of resistance to silver ions in Klebsiella pneumoniae. Antimicrob Agents Chemother, 29, 165–167.
  • Kim S, Choi JE, Choi J, Chung KH, Park K, Yi J, Ryu DY. (2009). Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol In Vitro, 23, 1076–1084.
  • Klasen HJ. (2000). A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns, 26, 131–138.
  • Kostenko V, Lyczak J, Turner K, Martinuzzi RJ. (2010). Impact of silver-containing wound dressings on bacterial biofilm viability and susceptibility to antibiotics during prolonged treatment. Antimicrob Agents Chemother, 54, 5120–5131.
  • Kramer JR. (1995). Aqueous silver in the environment. Proceedings, 3rd International Conference, Transport, Fate and Effects of Silver in the Environment, Madison, WI. 6–9, 19–30.
  • Lansdown AB, Williams A, Chandler S, Benfield S. (2005). Silver absorption and antibacterial efficacy of silver dressings. J Wound Care, 14, 155–160.
  • Le blanc G, Mastone J, Paradice A, Wilson B, Lockhart H, Robillard K. (1984). The influence of speciation on the toxicity of silver to fathead minnow (Pimephales promelas). Environ Tox Chem, 3, 37–46.
  • Lee JE, Heo JI, Park SH, Kim JH, Kho YJ, Kang HJ, Chung HY, Yoon JL, Lee JY. (2011). Calorie restriction (CR) reduces age-dependent decline of non-homologous end joining (NHEJ) activity in rat tissues. Exp Gerontol, 46, 891–896.
  • Leone M, Garnier F, Avidan M, Martin C. (2004). Catheter-associated urinary tract infections in intensive care units. Microbes Infect, 6, 1026–1032.
  • Li XZ, Nikaido H, Williams KE. (1997). Silver-resistant mutants of Escherichia coli display active efflux of Ag+ and are deficient in porins. J Bacteriol, 179, 6127–6132.
  • Liau SY, Read DC, Pugh WJ, Furr JR, Russell AD. (1997). Interaction of silver nitrate with readily identifiable groups: relationship to the antibacterial action of silver ions. Lett Appl Microbiol, 25, 279–283.
  • Liu W, Wu Y, Wang C, Li HC, Wang T, Liao CY, Cui L, Zhou QF, Yan B, Jiang GB. (2010). Impact of silver nanoparticles on human cells: effect of particle size. Nanotoxicology, 4, 319–330.
  • Loh JV, Percival SL, Woods EJ, Williams NJ, Cochrane CA. (2009). Silver resistance in MRSA isolated from wound and nasal sources in humans and animals. Int Wound J, 6, 32–38.
  • Lok CN, Ho CM, Chen R, He QY, Yu WY, Sun H, Tam PK, Chiu JF, Che CM. (2006). Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J Proteome Res, 5, 916–924.
  • Lok CN, Ho CM, Chen R, He QY, Yu WY, Sun H, Tam PK, Chiu JF, Che CM. (2007). Silver nanoparticles: partial oxidation and antibacterial activities. J Biol Inorg Chem, 12, 527–534.
  • Maillard J-Y. (2001). Virus susceptibility to biocides: an understanding. Rev Med Microbiol, 12, 63–74.
  • Maillard J-Y, Denyer SP. (2006a) Focus on silver. European Wound Management Association (EWMA) position document: The role of topical antimicrobials in managing wound infection. London: MEP Ltd.
  • Maillard J-Y, Denyer SP. (2006b) Demystifying silver. European Wound Management Association (EWMA) position document: The role of topical antimicrobials in managing wound infection. London: MEP Ltd.
  • Marambio-Jones C, Hoek EMV. (2010). A review of the antibacterial effects of silver nanomaterials and potential applications for human health and the environment. J Nanopart Res, 12, 1531–1551.
  • Martindale. (2002). The complete drug reference. 33rd ed. London: Pharmaceutical Press.
  • McHugh GL, Moellering RC, Hopkins CC, Swartz MN. (1975). Salmonella typhimurium resistant to silver nitrate, chloramphenicol, and ampicillin. Lancet, 1, 235–240.
  • Miao AJ, Schwehr KA, Xu C, Zhang SJ, Luo Z, Quigg A, Santschi PH. (2009). The algal toxicity of silver engineered nanoparticles and detoxification by exopolymeric substances. Environ Pollut, 157, 3034–3041.
  • Miyoshi H, Ohno H, Sakai K, Okamura N, Kourai H. (2010). Characterization and photochemical and antibacterial properties of highly stable silver nanoparticles prepared on montmorillonite clay in n-hexanol. J Colloid Interface Sci, 345, 433–441.
  • Modak SM, Sampath L, Fox CL Jr. (1988). Combined topical use of silver sulfadiazine and antibiotics as a possible solution to bacterial resistance in burn wounds. J Burn Care Rehabil, 9, 359–363.
  • Monteiro DR, Gorup LF, Takamiya AS, Ruvollo-Filho AC, de Camargo ER, Barbosa DB. (2009). The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silver. Int J Antimicrob Agents, 34, 103–110.
  • Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramírez JT, Yacaman MJ. (2005). The bactericidal effect of silver nanoparticles. Nanotechnology, 16, 2346–2353.
  • Moyer CA, Brentano L, Gravens DL, Margraf HW, Monafo WW Jr. (1965). Treatment of large human burns with 0.5 per cent silver nitrate solution. Arch Surg, 90, 812–867.
  • Nakane T, Gomyo H, Sasaki I, Kimoto Y, Hanzawa N, Teshima Y, Namba T. (2006). New antiaxillary odour deodorant made with antimicrobial Ag-zeolite (silver-exchanged zeolite). Int J Cosmet Sci, 28, 299–309.
  • Navarro E, Piccapietra F, Wagner B, Marconi F, Kaegi R, Odzak N, Sigg L, Behra R. (2008). Toxicity of silver nanoparticles to Chlamydomonas reinhardtii. Environ Sci Technol, 42, 8959–8964.
  • Nies DH. (1999). Microbial heavy-metal resistance. Appl Microbiol Biotechnol, 51, 730–750.
  • Olson ME, Harmon BG, Kollef MH. (2002). Silver-coated endotracheal tubes associated with reduced bacterial burden in the lungs of mechanically ventilated dogs. Chest, 121, 863–870.
  • Pal S, Tak YK, Song JM. (2007). Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli. Appl Environ Microbiol, 73, 1712–1720.
  • Percival SL, Bowler PG, Russell D. (2005). Bacterial resistance to silver in wound care. J Hosp Infect, 60, 1–7.
  • Percival SL, Bowler P, Woods EJ. (2008). Assessing the effect of an antimicrobial wound dressing on biofilms. Wound Repair Regen, 16, 52–57.
  • Percival SL, Slone W, Linton S, Okel T, Corum L, Thomas JG. (2011). The antimicrobial efficacy of a silver alginate dressing against a broad spectrum of clinically relevant wound isolates. Int Wound J, 8, 237–243.
  • Porel S, Ramakrishna D, Hariprasad E, Gupta AD, Radhakrishnan TP. (2011). Polymer thin film with in situ synthesized silver nanoparticles as a potent reusable bactericide. Curr Sci, 101, 927–933.
  • Project on Emerging Nanotechonologies. (2011). Consumer products inventory. The project on emerging nanotechnologies. Available at: http://www.nanotechproject.org/inventories/consumer/. Accessed on 31 January 2012.
  • Ratte HT. (1999). Bioaccumulation and toxicity of silver compounds: a review. Environ ToxChem, 18, 89–108.
  • Rhim JW, Hong SI, Park HM, Ng PK. (2006). Preparation and characterization of chitosan-based nanocomposite films with antimicrobial activity. J Agric Food Chem, 54, 5814–5822.
  • Roe D, Karandikar B, Bonn-Savage N, Gibbins B, Roullet JB. (2008). Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. J Antimicrob Chemother, 61, 869–876.
  • Russell AD, Hugo WB. (1994). Antimicrobial activity and action of silver. Prog Med Chem, 31, 351–370.
  • Samberg ME, Orndorff PE, Monteiro-Riviere NA. (2011). Antibacterial efficacy of silver nanoparticles of different sizes, surface conditions and synthesis methods. Nanotoxicology, 5, 244–253.
  • Spacciapoli P, Buxton D, Rothstein D, Friden P. (2001). Antimicrobial activity of silver nitrate against periodontal pathogens. J Periodont Res, 36, 108–113.
  • Schildkraut DE, Dao PT, Twist JP, Davis AT, Robillard KA. (1998). Determination of silver ions at submicrograms-per-liter levels using anodic square-wave stripping voltammetry. Environ Toxicol Chem, 17, 642–649.
  • Shafer MM, Overdier JT, Armstrong DE. (1998). Removal, partitioning, and fate of silver and other metals in wastewater treatment plants and effluent-receiving streams. Environ Toxicol Chem, 17, 630–641.
  • Shahverdi AR, Fakhimi A, Shahverdi HR, Minaian S. (2007). Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomedicine, 3, 168–171.
  • Silver S. (2003). Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. FEMS Microbiol Rev, 27, 341–353.
  • Silver S, Phung LT. (1996). Bacterial heavy metal resistance: new surprises. Annu Rev Microbiol, 50, 753–789.
  • Silver S, Phung LT. (2005). A bacterial view of the periodic table: genes and proteins for toxic inorganic ions. J Ind Microbiol Biotechnol, 32, 587–605.
  • Silver S, Phung LT, Silver G. (2006). Silver as biocides in burn and wound dressings and bacterial resistance to silver compounds. J Ind Microbiol Biotechnol, 33, 627–634.
  • Simon-Deckers A, Loo S, Mayne-L’hermite M, Herlin-Boime N, Menguy N, Reynaud C, Gouget B, Carrière M. (2009). Size-, composition- and shape-dependent toxicological impact of metal oxide nanoparticles and carbon nanotubes toward bacteria. Environ Sci Technol, 43, 8423–8429.
  • Smith IC, Carson BL. (1977). Trace metals in the environment. Vol 2. Ann Arbor, MI: Silver Ann Arbor Science.
  • Starodub ME, Trevors JT. (1989). Silver resistance in Escherichia coli R1. J Med Microbiol, 29, 101–110.
  • Starodub ME, Trevors JT. (1990). Mobilization of Escherichia coli R1 silver-resistance plasmid pJT1 by Tn5-Mob into Escherichia coli C600. Biol Met, 3, 24–27.
  • Su HL, Chou CC, Hung DJ, Lin SH, Pao IC, Lin JH, Huang FL, Dong RX, Lin JJ. (2009). The disruption of bacterial membrane integrity through ROS generation induced by nanohybrids of silver and clay. Biomaterials, 30, 5979–5987.
  • Su HL, Lin SH, Wei JC, Pao IC, Chiao SH, Huang CC, Lin SZ, Lin JJ. (2011). Novel nanohybrids of silver particles on clay platelets for inhibiting silver-resistant bacteria. PLoS ONE, 6, e21125.
  • Sujari ANA, Bowen HJM. (1986). Interactions of silver with humates and other species in natural waters. J Radioanal Nuclchem Lett, 106, 213–221.
  • Terhaar CJ, Ewell WS, Dziuba SP, White WW, Murphy PJ. (1977). A laboratory model for evaluating the behavior of heavy metals in an aquatic environment. Water Res, 11, 101–110.
  • Thomas S, McCubbin P. (2003). A comparison of the antimicrobial effects of four silver-containing dressings on three organisms. J Wound Care, 12, 101–107.
  • Toy LW, Macera L. (2011). Evidence-based review of silver dressing use on chronic wounds. J Am Acad Nurse Pract, 23, 183–192.
  • Wen LS, Santschi PH, Gill GA, Peternostro CL, Lehman RL. (1997). Colloidal and particulate silver in rivers and estuarine waters of Texas. Environ SciTechnol, 31, 723–731.
  • Wenzel RP, Hunting KJ, Osterman CA, Sande MA. (1976). Providencia stuartii, a hospital pathogen: potential factors for its emergence and transmission. Am J Epidemiol, 104, 170–180.
  • Wijnhoven SWP, Peijnenburg WJGM, Herbert CA, Hagens WI, Oomen AG, Heugens EHW, Roszek B. (2009). Nanosilver – a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicol, 3, 109–138.
  • Willie SN, Sturgeon RE, McLaren JW. (1994). Strategies for trace metal analysis in natural water samples. Proceedings, 2nd Argentum International Conference on the Transport, Fate, and Effects of Silver in the Environment. Madison, WI, USA, 11–14, 167–72.
  • Woods EJ, Cochrane CA, Percival SL. (2009). Prevalence of silver resistance genes in bacteria isolated from human and horse wounds. Vet Microbiol, 138, 325–329.
  • Xu XH, Brownlow WJ, Kyriacou SV, Wan Q, Viola JJ. (2004). Real-time probing of membrane transport in living microbial cells using single nanoparticle optics and living cell imaging. Biochemistry, 43, 10400–10413.
  • Yin HQ, Langford R, Burrell RE. (1999). Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. J Burn Care Rehabil, 20, 195–200.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.